Background image for footer

← Back to Blog

Using Real-World Evidence to Inform Better Patient Care

Share on LinkedIn
Using Real-World Evidence to Inform Better Patient Care

June 3, 2026

Using Real-World Evidence to Inform Better Patient Care

Real-world evidence (RWE) is clinical evidence about how a treatment performs in everyday practice — drawn from real-world data (RWD) like electronic health records, claims, registries, and patient-reported outcomes, rather than from a controlled trial alone. It answers a question randomized trials can’t: not can this work under ideal conditions, but does it work for the patients you actually treat.

Here’s the distinction that trips most people up, and the one regulators care about most.

What’s the difference between real-world data and real-world evidence?

Real-world data is the raw material; real-world evidence is the conclusion you draw from it. RWD is the source — EHRs, insurance claims, disease registries, device and wearable data, and patient-reported outcomes (ePRO). RWE is what emerges when that data is analyzed to support a clinical or regulatory decision. Collect RWD; generate RWE.

Real-world data (RWD)

Real-world evidence (RWE)

What it is

The underlying data

The clinical evidence derived from it

Sources

EHRs, claims, registries, ePRO, wearables, device logs

Analyses, comparisons, and outcome studies built on RWD

Example

3,000 patients’ post-surgical infection records

“Aqueous antisepsis reduced surgical-site infections vs. the comparator”

Used for

Feeding the analysis

Informing treatment decisions, labels, and coverage

The FDA formalized this same split in its real-world evidence framework, and both the FDA and EMA now accept fit-for-purpose RWE in regulatory submissions — a shift from RWE as a nice-to-have to RWE as a recognized source of evidence.

Why does real-world evidence matter for patient care?

Consider a patient with a broken leg. The surgeon proposes a few paths — non-surgical management, or one of several surgical interventions — and chooses based on the best tool they have: research published in the literature. But that model has a quiet flaw. The surgeon performing the procedure may never reach the skill level of the surgeon who authored the paper. The literature can say Surgery A is best while this surgeon gets better outcomes with Surgery B, because of their own hands. Being very good at a procedure doesn’t guarantee fewer complications — and the only way to know is to measure your own results.

That measurement is exactly what standard practice makes hard. Infection rates, mortality, DVT — all tracked while the patient is in the hospital, then invisible the moment they go home. In orthopedic trauma especially, most patients fall off the map once the pain stops. The surgeon only learns about a complication if the patient happens to come back.

Real-world evidence closes that gap. Patient-reported outcome data, collected on your own population after they leave, lets a clinician weigh their own results against their patient population and the general population — even against other surgeons. At a university research group I worked with, an orthopedic outcomes-tracking system captured pain scores, sleep scales, infection rates, peri-prosthetic fractures, and quality-of-life measures. It let surgeons refine their practice — and in some cases stop performing procedures the data showed they weren’t as good at as they’d believed.

How is real-world evidence collected?

The hard part was never the analysis — it’s getting clean, structured data out of the real world and into one place. A modern platform collects patient-reported outcomes remotely, before and after a procedure, so patients spend less time in clinic and clinicians still see what happens at home:

  • Before the procedure — baseline patient-reported outcomes captured remotely by the patient.

  • After the procedure — infection rates, hospital re-admissions, and mortality, entered by patients or care providers through a simple web or mobile form, by email, or pulled automatically from electronic medical records via eSource integration.

  • In one governed, compliant database — stored in the cloud, mined for best-practice insight, and fed into decision-support models — so the data a surgeon acts on reflects their patients, demographics, and circumstances, not a distant trial population.

For the patient with the broken leg, that’s the difference between a generic protocol and a plan shaped by the surgeon’s own measured outcomes.

Real-world evidence examples in clinical research

Two peer-reviewed studies show what this looks like in practice — both run on REDCap Cloud:

Both are RWE in the truest sense: data from the population actually being treated, collected where care happens, turned into evidence that changes practice. REDCap Cloud is built to capture patient-reported outcomes (ePRO) remotely and normalize disparate sources into one real-world data platform — the foundation any RWE program depends on.

Frequently Asked Questions (FAQ)

What is real-world evidence in clinical research?

Real-world evidence is clinical evidence about a treatment’s use and performance, derived from real-world data collected outside conventional randomized trials — from EHRs, claims, registries, and patient-reported outcomes. It shows how a therapy performs in routine practice, not just under trial conditions.

What is the difference between RWD and RWE?

Real-world data (RWD) is the raw source data — EHRs, claims, registries, ePRO, wearables. Real-world evidence (RWE) is the clinical evidence produced by analyzing that data. You collect RWD to generate RWE.

What is an example of real-world evidence?

Tracking surgical-site infections across thousands of patients at 18 hospitals for 90 days after surgery — then using that data to compare antisepsis approaches — is real-world evidence: outcomes measured in routine care and analyzed to inform a clinical decision.

How is real-world evidence used in regulatory submissions?

Both the FDA and EMA accept fit-for-purpose RWE to support regulatory decisions, provided the underlying data is reliable and relevant and the study is well-designed. RWE increasingly supplements traditional trial data in labeling and post-market decisions.

Is patient-reported outcome (PRO) data real-world evidence?

PRO data is a real-world data source. It becomes real-world evidence when it’s analyzed to answer a clinical question — for example, comparing recovery trajectories across a treated population.

Clinical Research digital data wave background image

Book a Demo →

Start your journey with REDCap Cloud today – scale for tomorrows novel therapies.